Eleonora Olivetta

Rome, 00161, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Distinct Cytokine Landscapes Induced by Influenza a Virus, RSV, and SARS-CoV-2 in Older Adults (65+) Using an Ex Vivo Whole Blood Stimulation Model.

Distinct Cytokine Landscapes Induced by Influenza a Virus, RSV, and SARS-CoV-2 in Older Adults (65+) Using an Ex Vivo Whole Blood Stimulation Model.

Journal: Pathogens (Basel, Switzerland)
Published: December 15, 2025

IL-6 and IL-8 elevations after co-administration of COVID-19 and influenza vaccines are associated with lower anti-spike IgG titers at three and six months post-vaccination.

IL-6 and IL-8 elevations after co-administration of COVID-19 and influenza vaccines are associated with lower anti-spike IgG titers at three and six months post-vaccination.

Journal: Cytokine
Published: June 12, 2025

Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers.

Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers.

Journal: Vaccine
Published: June 27, 2024

Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu.

Extracellular vesicle-based anti-HOXB7 CD8+ T cell-specific vaccination strengthens antitumor effects induced by vaccination against Her2/neu.

Journal: Cancer gene therapy
Published: May 24, 2024

A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study.

A 12-month follow-up of the immune response to SARS-CoV-2 primary vaccination: evidence from a real-world study.

Journal: Frontiers in immunology
Published: August 03, 2023

Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab.

Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab.

Journal: Lupus
Published: January 06, 2023

Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.

Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study.

Journal: Frontiers in immunology
Published: August 17, 2022

T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.

T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.

Journal: Journal of the American Medical Directors Association
Published: July 29, 2022

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.

Journal: Diagnostic microbiology and infectious disease
Published: November 06, 2021

Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles.

Long-Term Antitumor CD8+ T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles.

Journal: Cancers
Published: April 01, 2021

The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.

The C-Terminal Domain of Nefmut Is Dispensable for the CD8+ T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.

Journal: Vaccines
Published: March 19, 2021

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.

Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.

Journal: Diagnostic microbiology and infectious disease
Published: February 23, 2021
Showing 1-12 of 25

Last Updated: 09/26/2026